What changed in Medtronic plc's latest annual report
In the year ended 24 Apr 2026, Medtronic plc's revenue rose 8.4% to USD 36.36bn, from USD 33.54bn; net income rose 3% to USD 4.80bn, from USD 4.66bn; cash and cash equivalents fell 12.1% to USD 1.95bn, from USD 2.22bn.
Year ended 24 Apr 2026. Source: 10-K filed 18 Jun 2026, read it on SEC EDGAR.
USD 33.54bn to USD 36.36bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 33.54bn | 36.36bn | Up 8.4% |
| Net income | 4.66bn | 4.80bn | Up 3% |
| Total assets | 91.68bn | 93.03bn | Up 1.5% |
| Total liabilities | 43.42bn | 42.96bn | Down 1.1% |
| Cash and cash equivalents | 2.22bn | 1.95bn | Down 12.1% |
| Shareholders' equity | 48.02bn | 49.46bn | Up 3% |
Questions people ask
Did Medtronic plc's revenue grow last year?
Revenue grew 8.4%, from USD 33.54bn to USD 36.36bn in the year ended 24 Apr 2026.
Is Medtronic plc profitable?
Yes. Net income was USD 4.80bn in the year ended 24 Apr 2026. The year before: USD 4.66bn.
How much cash and debt does Medtronic plc have?
At its latest year end (24 Apr 2026), Medtronic plc reported cash and cash equivalents of USD 1.95bn.
Where do these numbers come from?
From Medtronic plc's own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Medtronic plc?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demo